Literature DB >> 7844229

Low implantation rate after in-vitro fertilization in patients with hydrosalpinges diagnosed by ultrasonography.

A N Andersen1, Z Yue, F J Meng, K Petersen.   

Abstract

The purpose of this study was to assess whether patients with tubal infertility and a hydrosalpinx have a reduced implantation rate after in-vitro fertilization. The study included 741 patients who had 1190 consecutive oocyte aspirations. The presence or absence of hydrosalpinges was assessed by transvaginal ultrasonography on day 2 of all cycles. In 62 patients treated in 104 cycles a hydrosalpinx was diagnosed, whereas 493 patients treated in 813 cycles had no hydrosalpinx and eight patients treated in 16 cycles had uncertain hydrosalpinx. The results show that the presence of a hydrosalpinx is associated with a reduced pregnancy rate per aspiration (19.2 versus 32.6%; P < 0.01), reduced implantation rate (2.9 versus 10.3%, P < 0.0005), reduced delivery rate per aspiration (5.8 versus 20.9%, P < 0.0005), reduced delivery rate per embryo transfer (6.6 versus 22.8%, P < 0.0005) and increased early pregnancy loss (70 versus 36%, P < 0.005). Among 178 patients with unexplained infertility or other infertility factors treated with 257 aspirations the results were similar to those in patients with tubal infertility without a hydrosalpinx. In conclusion, the presence of a hydrosalpinx does not impair the number of embryos transferred but seems to impair the implantation process. We hypothesize that this may be due to leakage of fluid into the uterine cavity which may disturb the receptivity of the endometrium and/or the developing embryos.

Entities:  

Mesh:

Year:  1994        PMID: 7844229     DOI: 10.1093/oxfordjournals.humrep.a138362

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  22 in total

1.  The effect of hydrosalpinges on IVF-ET outcome.

Authors:  L I Barmat; E Rauch; S Spandorfer; A Kowalik; E S Sills; G Schattman; H C Liu; Z Rosenwaks
Journal:  J Assist Reprod Genet       Date:  1999-08       Impact factor: 3.412

2.  Controlled ovarian hyperstimulation adversely affects implantation following in vitro fertilization-embryo transfer.

Authors:  J H Check; J K Choe; D Katsoff; D Summers-Chase; C Wilson
Journal:  J Assist Reprod Genet       Date:  1999-09       Impact factor: 3.412

3.  How members of the Society for Reproductive Endocrinology and Infertility and Society of Reproductive Surgeons evaluate, define, and manage hydrosalpinges.

Authors:  Kenan Omurtag; Natalia M Grindler; Kimberly A Roehl; Gordon Wright Bates; Angeline N Beltsos; Randall R Odem; Emily S Jungheim
Journal:  Fertil Steril       Date:  2012-03-09       Impact factor: 7.329

Review 4.  Implantation failure: molecular mechanisms and clinical treatment.

Authors:  Hakan Cakmak; Hugh S Taylor
Journal:  Hum Reprod Update       Date:  2010-08-21       Impact factor: 15.610

5.  Salpingectomy for repeated embryo nonimplantation after in vitro fertilization in patients with severe tubal factor infertility.

Authors:  H Dechaud; T Anahory; N Aligier; F Arnal; H Humeau; B Hedon
Journal:  J Assist Reprod Genet       Date:  2000-04       Impact factor: 3.412

6.  The presence of hydrosalpinx may not adversely affect the implantation and pregnancy rates in in vitro fertilization treatment.

Authors:  E H Ng; W S Yeung; P C Ho
Journal:  J Assist Reprod Genet       Date:  1997-10       Impact factor: 3.412

7.  An increased number of replaced embryos counteracts the adverse effect of hydrosalpinges on IVF/ET outcome.

Authors:  K H Abd-el-Maeboud; E al-Dein M Khalifa; E S el-Hussein
Journal:  J Assist Reprod Genet       Date:  1998-01       Impact factor: 3.412

8.  Is there any need for diagnostic laparoscopy in couples undergoing intracytoplasmic sperm injection for severe male-factor infertility.

Authors:  A Aytoz; H Tournaye; M Camus; F Ubaldi; G Verheyen; A Van Steirteghem; P Devroey
Journal:  J Assist Reprod Genet       Date:  1998-02       Impact factor: 3.412

9.  State-mandated insurance coverage is associated with the approach to hydrosalpinges before IVF.

Authors:  Kenan Omurtag; Natalia M Grindler; Kimberly A Roehl; G Wright Bates; Angeline N Beltsos; Randall R Odem; Emily S Jungheim
Journal:  Reprod Biomed Online       Date:  2014-03-24       Impact factor: 3.828

Review 10.  Surgical treatment for tubal disease in women due to undergo in vitro fertilisation.

Authors:  Neil Johnson; Sabine van Voorst; Martin C Sowter; Annika Strandell; Ben Willem J Mol
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.